GLPwatch
Byetta vs Soliqua
Drug comparison
Last updated 2026-05-28 15:46 UTCByetta (exenatide by AstraZeneca) and Soliqua (lixisenatide by Sanofi) are both injectable medications for type 2 diabetes. Byetta contains the active ingredient exenatide, while Soliqua contains lixisenatide. Both are taken as subcutaneous injections, meaning they are injected under the skin.
AI summary of the sources below.
| Byetta | Soliqua | |
|---|---|---|
| Active ingredient | exenatide | lixisenatide |
| Manufacturer | astrazeneca | sanofi |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes |
| Label updated | 2025-09-02 | 2026-03-18 |